Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures...
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Pfizer's $70 billion U.S. investment deal exempts it from tariffs, boosting drugmaker stocks.
Trump's deal with Pfizer exempts it from tariffs, boosting drugmaker stocks.